Among these targets, CDK5 and GRIN1 were significantly downregulated (Figure 5A, 5B), and MMP2 was significantly upregulated in the entorhinal cortex in AD patients compared to controls (Figure 5C). This evidence concerns the gene CDK5 and Alzheimer disease.